Bicycle Therapeutics Plc
Research Bicycle Therapeutics Plc (BCYC) on Bullrun: market cap USD 221.15M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBCYC
- ExchangeNASDAQ
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 221.15M
- Financial periodQ2 2026
- RevenueUSD 629.00K
- Net income-USD 50.33M
- Free cash flow-USD 49.87M
Valuation Snapshot
latest market cap is USD 221.15M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 72.59M | -USD 218.96M | -USD 252.03M | n/a | -3.16 | USD 628.11M | USD 16.85M | USD 609.98M |
| FY2024 | USD 35.28M | -USD 169.03M | -USD 165.96M | n/a | -2.9 | USD 879.52M | USD 9.49M | USD 793.06M |
| FY2023 | USD 26.98M | -USD 180.66M | -USD 63.56M | n/a | -5.08 | USD 526.42M | USD 30.70M | USD 370.93M |
| FY2022 | USD 14.46M | -USD 112.72M | -USD 105.10M | n/a | -3.8 | USD 339.15M | USD 30.32M | USD 270.78M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 221.15M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 491.12M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 966.86M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 766.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 878.81M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.80B | n/a | n/a | n/a |
About Bicycle Therapeutics Plc
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bicycle Therapeutics Plc's market cap?
Bicycle Therapeutics Plc's market capitalization is USD 221.15M.
What does Bicycle Therapeutics Plc do?
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.